Medicare Expands Coverage For Spinal Cord Stimulation To Treat Diabetic Peripheral Neuropathy

Nevro Executives Say Their Device Offers An Option For Patients With Pain

Medicare’s recent expansion of coverage for spinal cord stimulation therapy to treat diabetic peripheral neuropathy could mean relief for some 11 million Americans. Executives from Redwood City, CA device maker Nevro talked to Medtech Insight about the expansion and what it means for patients who use their technology.

NEVRO HFX
• Source: Nevro

Millions of Americans with diabetes struggle with diabetic peripheral neuropathy, an often painful complication of the disease that usually starts in the feet and legs before moving up to the hands and arms.

Common symptoms, which usually worsen at night, can include numbness, reduced ability to feel pain or temperature changes, tingling and burning, sharp pain and cramps, muscle weakness, severe foot damage,...

More from Diabetic Care

More from Device Area